W-J Chng

737 total citations
7 papers, 452 citations indexed

About

W-J Chng is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, W-J Chng has authored 7 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in W-J Chng's work include Protein Degradation and Inhibitors (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). W-J Chng is often cited by papers focused on Protein Degradation and Inhibitors (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). W-J Chng collaborates with scholars based in Singapore, United Kingdom and China. W-J Chng's co-authors include Siok‐Bian Ng, Tae‐Hoon Chung, Rafaël Fonseca, George Mulligan, Natalia González-Paz, Marta Chesi, Thomas S. Y. Chan, Albert K. W. Lie, WS Kim and YL Kwong and has published in prestigious journals such as Leukemia, Bone Marrow Transplantation and Singapore Medical Journal.

In The Last Decade

W-J Chng

7 papers receiving 447 citations

Peers

W-J Chng
Gillian Turner United Kingdom
Τατιάνα Τζένου Greece
Vaishalee P. Kenkre United States
Olga Gielen Belgium
Bertrand Montpellier France
Stefan Norin Sweden
Dominique Penther France
G Stranks United Kingdom
Scott D. Lunin United States
M. Lenoci Italy
Gillian Turner United Kingdom
W-J Chng
Citations per year, relative to W-J Chng W-J Chng (= 1×) peers Gillian Turner

Countries citing papers authored by W-J Chng

Since Specialization
Citations

This map shows the geographic impact of W-J Chng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W-J Chng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W-J Chng more than expected).

Fields of papers citing papers by W-J Chng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W-J Chng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W-J Chng. The network helps show where W-J Chng may publish in the future.

Co-authorship network of co-authors of W-J Chng

This figure shows the co-authorship network connecting the top 25 collaborators of W-J Chng. A scholar is included among the top collaborators of W-J Chng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W-J Chng. W-J Chng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
2.
Selvarajan, Viknesvaran, Motomi Osato, Junfang Yan, et al.. (2017). RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC. Leukemia. 31(10). 2219–2227. 51 indexed citations
3.
Mel, Sanjay De, Melissa Ooi, Tan Ding, et al.. (2016). The Singapore Myeloma Study Group Consensus Guidelines for the management of patients with multiple myeloma. Singapore Medical Journal. 58(2). 55–71. 8 indexed citations
4.
Tse, Eric, Thomas S. Y. Chan, W-J Chng, et al.. (2014). Allogeneic haematopoietic SCT for natural killer/T-cell lymphoma: a multicentre analysis from the Asia Lymphoma Study Group. Bone Marrow Transplantation. 49(7). 902–906. 64 indexed citations
5.
Tang, Tiffany, Lei Tan, Siok‐Bian Ng, et al.. (2013). Type II EATL (epitheliotropic intestinal T-cell lymphoma): a neoplasm of intra-epithelial T-cells with predominant CD8αα phenotype. Leukemia. 27(8). 1688–1696. 96 indexed citations
6.
Huo, Jianxin, Shunliang Xu, Binshan Lin, W-J Chng, & Kong‐Peng Lam. (2012). Fas apoptosis inhibitory molecule is upregulated by IGF-1 signaling and modulates Akt activation and IRF4 expression in multiple myeloma. Leukemia. 27(5). 1165–1171. 22 indexed citations
7.
Chng, W-J, Tae‐Hoon Chung, Siok‐Bian Ng, et al.. (2011). Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma. Leukemia. 25(6). 1026–1035. 210 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gillian Turner Breakdown of academic impact, for papers by Τατιάνα Τζένου Breakdown of academic impact, for papers by Vaishalee P. Kenkre Breakdown of academic impact, for papers by Olga Gielen Breakdown of academic impact, for papers by Bertrand Montpellier Breakdown of academic impact, for papers by Stefan Norin Breakdown of academic impact, for papers by Dominique Penther Breakdown of academic impact, for papers by G Stranks Breakdown of academic impact, for papers by Scott D. Lunin Breakdown of academic impact, for papers by M. Lenoci
Rankless by CCL
2026